Wang et al. further demonstrated that upregulation of NRF2 and ferroptosis-related genes such as GPX4, SLC7A11, and FTL can mitigate sorafenib-induced ferroptosis in liver cancer cells [50]. The gene discussed is GPX4; the disease is liver cancer.